Aquatic Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Aquatic Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.29M	Buy	36,670 +19,687	+116%	+$1.98M	0.15%	168
2026 Q1	$1.57M	Buy	+16,983	New	+$1.6M	0.05%	445
2025 Q4	–	Sell	-63,946	Closed	-$4.69M	–	1619
2025 Q3	$4.69M	Buy	63,946 +27,049	+73%	+$1.72M	0.09%	278
2025 Q2	$1.88M	Sell	36,897 -9,413	-20%	-$419K	0.04%	488
2025 Q1	$2.09M	Buy	46,310 +23,721	+105%	+$1.12M	0.05%	402
2024 Q4	$934K	Buy	22,589 +4,989	+28%	+$208K	0.03%	566
2024 Q3	$686K	Buy	17,600 +11,900	+209%	+$475K	0.02%	581
2024 Q2	$195K	Sell	5,700 -10,000	-64%	-$262K	0.01%	761
2024 Q1	$394K	Buy	+15,700	New	+$432K	0.01%	601
2023 Q4	–	Sell	-3,900	Closed	-$123K	–	1515
2023 Q3	$123K	Buy	+3,900	New	+$107K	0.01%	782
2022 Q4	–	Sell	-7,000	Closed	-$147K	–	1642
2022 Q3	$147K	Buy	7,000 +6,900	+6,900%	+$166K	0.01%	679
2022 Q2	$2K	Buy	+100	New	+$2.36K	﹤0.01%	1112
2022 Q1	–	Sell	-700	Closed	-$11K	–	1338
2021 Q4	$11K	Buy	+700	New	+$10.9K	0.02%	770

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's MIRM Position: Q2 2026 in Review

Aquatic Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 116% in Q2 2026, buying an estimated $1.98M and bringing the position to 36,670 shares worth $4.29M. The position accounts for 0.15% of the portfolio, ranked #168.

Aquatic Capital Management first reported a position in MIRM in Q4 2021 and has held it in 13 quarters since. The position peaked at $4.69M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Aquatic Capital Management held 36,670 shares of Mirum Pharmaceuticals worth $4.29M as of Q2 2026.
Aquatic Capital Management bought 19,687 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.98M.
Mirum Pharmaceuticals made up 0.15% of Aquatic Capital Management's portfolio in Q2 2026, its #168 holding.
Aquatic Capital Management first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 13 quarters since.
Aquatic Capital Management's Mirum Pharmaceuticals position peaked at $4.69M in Q3 2025.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.